Literature DB >> 17360097

Drug administration in animal studies of cardiac arrest does not reflect human clinical experience.

Joshua C Reynolds1, Jon C Rittenberger, James J Menegazzi.   

Abstract

INTRODUCTION: To date, there is no evidence showing a benefit from any advanced cardiac life support (ACLS) medication in out-of-hospital cardiac arrest (OOHCA), despite animal data to the contrary. One explanation may be a difference in the time to first drug administration. Our previous work has shown the mean time to first drug administration in clinical trials is 19.4min. We hypothesized that the average time to drug administration in large animal experiments occurs earlier than in OOHCA clinical trials.
METHODS: We conducted a literature review between 1990 and 2006 in MEDLINE using the following MeSH headings: swine, dogs, resuscitation, heart arrest, EMS, EMT, ambulance, ventricular fibrillation, drug therapy, epinephrine, vasopressin, amiodarone, lidocaine, magnesium, and sodium bicarbonate. We reviewed the abstracts of 331 studies and 197 full manuscripts. Exclusion criteria included: non-peer reviewed, all without primary animal data, and traumatic models. From these, we identified 119 papers that contained unique information on time to medication administration. The data are reported as mean, ranges, and 95% confidence intervals. Mean time to first drug administration in animal laboratory studies and clinical trials was compared with a t-test. Regression analysis was performed to determine if time to drug predicted ROSC.
RESULTS: Mean time to first drug administration in 2378 animals was 9.5min (range 3.0-28.0; 95% CI around mean 2.78, 16.22). This is less than the time reported in clinical trials (19.4min, p<0.001). Time to drug predicted ROSC (odds ratio 0.844; 95% CI 0.738, 0.966).
CONCLUSION: Shorter drug delivery time in animal models of cardiac arrest may be one reason for the failure of animal studies to translate successfully into the clinical arena.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360097      PMCID: PMC2039906          DOI: 10.1016/j.resuscitation.2006.10.032

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  133 in total

1.  Resuscitation after cardiac arrest: a 3-phase time-sensitive model.

Authors:  Myron L Weisfeldt; Lance B Becker
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

2.  Survival with full neurologic recovery after prolonged cardiopulmonary resuscitation with a combination of vasopressin and epinephrine in pigs.

Authors:  Karl H Stadlbauer; Horst G Wagner-Berger; Volker Wenzel; Wolfgang G Voelckel; Anette C Krismer; Günter Klima; Klaus Rheinberger; Sebastian Pechlaner; Viktoria D Mayr; Karl H Lindner
Journal:  Anesth Analg       Date:  2003-06       Impact factor: 5.108

3.  Endothelin-1 elevates regional cerebral perfusion during prolonged ventricular fibrillation cardiac arrest in pigs.

Authors:  Michael Holzer; Fritz Sterz; Wilhelm Behringer; Elisabeth Oschatz; Julia Kofler; Philip Eisenburger; Harald Kittler; Reinhard Konschitzky; Anton N Laggner
Journal:  Resuscitation       Date:  2002-12       Impact factor: 5.262

4.  Survival and normal neurological outcome after CPR with periodic Gz acceleration and vasopressin.

Authors:  Jose A Adams; Jorge Bassuk; Dongmei Wu; Paul Kurlansky
Journal:  Resuscitation       Date:  2003-02       Impact factor: 5.262

5.  Effects of epinephrine and vasopressin on median fibrillation frequency and defibrillation success in a porcine model of cardiopulmonary resuscitation.

Authors:  H U Strohmenger; K H Lindner; A W Prengel; E G Pfenninger; U Bothner; K G Lurie
Journal:  Resuscitation       Date:  1996-02       Impact factor: 5.262

6.  Effect of vehicle on the nasal absorption of epinephrine during cardiopulmonary resuscitation.

Authors:  B E Bleske; T L Rice; E W Warren; D A Giacherio; L J Gilligan; K D Massey; C E Chrisp; A R Tait
Journal:  Pharmacotherapy       Date:  1996 Nov-Dec       Impact factor: 4.705

7.  Precountershock cardiopulmonary resuscitation improves ventricular fibrillation median frequency and myocardial readiness for successful defibrillation from prolonged ventricular fibrillation: a randomized, controlled swine study.

Authors:  Robert Allen Berg; Ronald Willard Hilwig; Karl B Kern; Gordon Allen Ewy
Journal:  Ann Emerg Med       Date:  2002-12       Impact factor: 5.721

8.  Neither vasopressin nor amiodarone improve CPR outcome in an animal model of hypothermic cardiac arrest.

Authors:  B Schwarz; P Mair; H Wagner-Berger; K H Stadlbauer; S Girg; V Wenzel; K H Lindner
Journal:  Acta Anaesthesiol Scand       Date:  2003-10       Impact factor: 2.105

9.  Cardiac arrest survival as a function of ambulance deployment strategy in a large urban emergency medical services system.

Authors:  David E Persse; Craig B Key; Richard N Bradley; Charles C Miller; Atul Dhingra
Journal:  Resuscitation       Date:  2003-10       Impact factor: 5.262

10.  Increased cortical cerebral blood flow by continuous infusion of adrenaline (epinephrine) during experimental cardiopulmonary resuscitation.

Authors:  Jakob Johansson; Rolf Gedeborg; Samar Basu; Sten Rubertsson
Journal:  Resuscitation       Date:  2003-06       Impact factor: 5.262

View more
  15 in total

Review 1.  Use of inotropes and vasopressor agents in critically ill patients.

Authors:  Mansoor N Bangash; Ming-Li Kong; Rupert M Pearse
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Conceptual models of coronary perfusion pressure and their relationship to defibrillation success in a porcine model of prolonged out-of-hospital cardiac arrest.

Authors:  Joshua C Reynolds; David D Salcido; James J Menegazzi
Journal:  Resuscitation       Date:  2012-01-20       Impact factor: 5.262

3.  Terlipressin versus adrenaline in an infant animal model of asphyxial cardiac arrest.

Authors:  Jesús López-Herce; Bárbara Fernández; Javier Urbano; Santiago Mencía; Maria J Solana; Jimena del Castillo; Antonio Rodríguez-Núñez; Jose M Bellón
Journal:  Intensive Care Med       Date:  2010-03-18       Impact factor: 17.440

4.  Effect of neuromonitor-guided titrated care on brain tissue hypoxia after opioid overdose cardiac arrest.

Authors:  Jonathan Elmer; Katharyn L Flickinger; Maighdlin W Anderson; Allison C Koller; Matthew L Sundermann; Cameron Dezfulian; David O Okonkwo; Lori A Shutter; David D Salcido; Clifton W Callaway; James J Menegazzi
Journal:  Resuscitation       Date:  2018-04-18       Impact factor: 5.262

5.  Coronary perfusion pressure and return of spontaneous circulation after prolonged cardiac arrest.

Authors:  Joshua C Reynolds; David D Salcido; James J Menegazzi
Journal:  Prehosp Emerg Care       Date:  2010 Jan-Mar       Impact factor: 3.077

6.  Time to Epinephrine and Survival After Pediatric In-Hospital Cardiac Arrest.

Authors:  Lars W Andersen; Katherine M Berg; Brian Z Saindon; Joseph M Massaro; Tia T Raymond; Robert A Berg; Vinay M Nadkarni; Michael W Donnino
Journal:  JAMA       Date:  2015-08-25       Impact factor: 56.272

7.  Increasing CPR duration prior to first defibrillation does not improve return of spontaneous circulation or survival in a swine model of prolonged ventricular fibrillation.

Authors:  Sudhakar Sattur; Karl B Kern
Journal:  Resuscitation       Date:  2008-12-25       Impact factor: 5.262

8.  Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty.

Authors:  Jonathan Kimmelman; Alex John London
Journal:  PLoS Med       Date:  2011-03-08       Impact factor: 11.069

9.  An experimental study: does the neuroprotective effect increase when hypothermia deepens after traumatic brain injury?

Authors:  Abdullah Sadik Girisgin; Erdal Kalkan; Mehmet Ergin; Fatih Keskin; Zerrin Defne Dundar; Sedat Kebapcioglu; Sedat Kocak; Basar Cander
Journal:  Iran Red Crescent Med J       Date:  2015-04-25       Impact factor: 0.611

Review 10.  Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments.

Authors:  Valerie C Henderson; Jonathan Kimmelman; Dean Fergusson; Jeremy M Grimshaw; Dan G Hackam
Journal:  PLoS Med       Date:  2013-07-23       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.